1. Basic and Clinical Neuroscience, Clinical Neurosciences Clinical Academic Group, King's College London, London, United Kingdom;
2. Department of Brain Science, Imperial College London, London, United Kingdom;
3. Elettra Sincrotrone Trieste, Basovizza, Trieste, ItalyStructural Biology; NMR; Protein Aggregation; Neurodegeneration; Muscle Proteins; Macromolecular Interactions
Professor of Chemistry and Molecular Biology at King's College London
Distinguished Scientist at Elettra Sincrotrone Trieste affiliated also Imperial College London
Full Professor at the Scuola Normale Superiore di Pisa
Member of the Academia Europaea (MAE), AcademiaNet and the European Molecular Biology Organization
SAB Member for the ALBA Spanish Synchrotron (2022-present)
Elected Committee Member of Novo Nordisk Foundation (2023-2027)
Elected Member of the Ampere NMR Committee (2022-2027)
Member of the Scientific Advisory Board of CERIC (C-European Research Infrastructure Consortium) (2011 - present)
Panel Member of the Scientific Advisory Board of University Autonoma Catalunya (2016-present)
1. Centre for Precision Health, Edith Cowan University, Perth, Australia;
2. Institute for Glycome Study, Shantou University Medical College, Shantou, China;
3. School of Medical and Health Sciences, Edith Cowan University, Perth, AustraliaGlycomics; Public Health; Genetic Epidemiology; Chronic Disorders
Professor of Public Health in the Centre for Precision Health and School of Medical and Health Sciences
Member of the Standing Committee of the Human Glycome Project
Australian National Representative of European Association of Preventive, Predictive and Personalised Medicine (EPMA)
Fellow of Public Health, Royal College of Physicians, United Kingdom (FFPH)
Fellow of the Royal Society of Biology of United Kingdom (FRSB)
Fellow of the Royal Society of Medicine of United Kingdom (FRSM)
Academic editor of PloS ONE (PLOS)
Associate editor of EPMA Journal (Springer-Nature)
Regional editor of Journal of Global Health (Edinburgh University Press)
Regional editor of OMICS: A Journal of Integrative Biology (Mary Ann Liebert)
Regional editor of Journal of Human Hypertension (Nature)
Leader of the Suboptimal Health and Glycomics research group, within the School of Medical and Health Sciences, and is the Suboptimal Health Program Lead in the Centre for Precision Health, an ECU strategic Research Centre
1. Department of Physics and Astronomy "G.Galilei", University of Padua, Padova, Italy
2. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy
3. Padova Neuroscience Center, Padova, ItalyCharcot-marie-tooth; Parkinson’s Diseases; Bioinformatics; Biology
Associate Professor at the Dept. of Physics and Astronomy, University of Padova
Scientific Cordinator and Executive (VP, SVP, CFO, CTO etc.) of PNC-SISMUR Infrastructure for Cellular Imaging at the Venetian Institute of Molecular Medicine (VIMM), Padova
Group Leader at the Venetian Institute of Molecular Medicine (VIMM), Padova
1. Western University of Health Sciences, Graduate School of Biomedical Science, Pomona, CA, United States;
2. Department of Psychiatry Wright University Boonshoft School of Medicine, Dayton, OH, United States;
3. Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT, United StatesGenetics of Alcoholism; Neuropsychiatry and Genetics; Nutritional Genetics; Pharmacogenetics
Well-known American Scientist in Psychopharmacology and Psychiatric Genetics.
Distinguished Top Professional to be featured in the Wall Street Journal.
Editor -in-Chief of Current Psychopharmacology, Addiction Psychiatry, and Theranostic and Pharmacological Sciences.
Associate Editor for Frontiers in Psychiatry and Frontiers in Public Health
Regional Editor for Current Pharmaceutical & Biotechnology. Recipient of NIH grants and has been awarded Lifetime Achievements,
Distinguished Honorary Doctors of Humane Letters;
Life-time Honorary Professor at ELTE Eötvös Loránd University, Hungary
Distinguished Honorary Professor at Adelson School of Medicine, Ariel University, Israel.
Adjunct professor at Western University, University of Vermont, Wright School of Medicine
Executive Chairman and CEO of TranspliceGen Therapeutics, Inc.
Stanford university credited him as top 2% of the World Best scientist list (2023).
The International Research Awards on Neurology and Neuro Disorders awarded him the “Best Researcher Award 2023”.
Centro de Investigación Biomédica en Red de Cáncer, Madrid, SpainIdentification of new genes involved in cancer; Its characterization and translation to clinic; Identification and validation of new targets for anticancer drug discovery
Head of the Assay Development Group at the Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid
Leader of the Molecular Biology of Cancer Lab in Biomedical Institute of Seville (IBiS/CSIC)
1. Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment;
2. Henan Key Laboratory of Cancer Epigenetics;
3. Cancer Hospital, The First Affiliated Hospital（College of Clinical Medicine）of Henan University of Science and Technology, ChinaBasic and Clinical Research on Gastrointestinal Cancer
Deputy Dean, Medical College, Henan University of Science and Technology
President, The First Affiliated Hospital of Henan University of Science and Technology
President, Cancer Hospital, The First Affiliated Hospital of Henan University of Science and Technology
Editor-in-Chief, Esophageal Cancer and Diseases of the Esophagus
Director, Esophageal Photodynamic Therapy Training Base, China
Director, Henan Provincial Key Laboratory of Epigenetics
Director, Henan Provincial International Joint Key Laboratory of Infection and Esophageal Cancer
Director, Henan Provincial Engineering Research Center for Esophageal Cancer Prevention and Control
Director, Henan Provincial Academician Workstation for Esophageal Cancer Prevention and Control
Discipline Leader, Medical Bioinformatics Ph.D. Program, Henan University of Science and Technology
Professional Memberships and Leadership Roles:
Member, American Society of Clinical Oncology (ASCO)
Chair, Esophageal Cancer Committee, Chinese Society of Clinical Oncology (CSCO)
Vice Chair, Photodynamic Therapy Committee, Chinese Anti-Cancer Association (CACA)
Vice Chair, Expert Committee on Photodynamic Therapy, Chinese Society of Clinical Oncology (CSCO)
Chair, Henan Provincial Anti-Cancer Association – Esophageal Cancer Committee
Vice Chair, Henan Medical Association – Oncology Committee
Vice President, First Henan Provincial Physicians Association – Oncology Physicians Branch
Vice Chair, Henan Hospital Association – Cancer Hospital/Department Management Branch
Chair, Youth Committee of Henan Provincial Anti-Cancer Association – Precision Medicine
Vice Chair, Henan Provincial Anti-Cancer Association – Chemotherapy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Photodynamic Therapy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Tumor Epidemiology and Etiology Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Oncologic Endoscopy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Committee on Precision Diagnosis and Treatment
Vice Chair, Henan Provincial Anti-Cancer Association – Targeted Therapy Committee
Vice Chair, Henan Provincial Geriatrics Society – Oncology Committee
Vice President, Luoyang Anti-Cancer Association
Chair, Luoyang Municipal Oncology Committee
School of Basic Medical Science, Henan University, Kaifeng, ChinaMedical Microbiology and Immunology; Nuclear Protein PCNP(PEST proteolytic signal-containing nuclear protein); Tumorigenesis; Tumor Suppression Gene
Professor | Vice Dean, School of Medicine, Henan University
Distinguished Professor, The First Affiliated Hospital of Henan University
Vice President, Henan Immunological Society
Director, Henan International Joint Laboratory of Nucleoprotein Gene Regulation
Founder and First Chairman, Henan Industrial Technology Innovation Strategic Alliance for Precision Diagnosis and Treatment of Cancer
Honorary President, Henan Health Science Society
Chief Science Communicator, Henan Science Communication Expert Group
Founder of the Kaifeng Medical Science Communication Team
Council Member, Chinese Society of Microbiology
Former Vice President, Henan Society of Microbiology
Founder and First Chair, Henan Specialized Committee on Infection, Molecular Immunology
Chair, Sub-committee on Biomedical Research Ethics, Henan University
Founder and First Director, Henan Specialized Committee on Infectious Diseases and Biosafety
Founder and Honorary Director, Kaifeng Key Laboratory of Infectious Diseases and Biosafety
School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China.Cell Signaling Transduction; PTEN; CART; Biotechnology
Distinguished Professor, Henan University, Huanghe Scholar
Standing Council Member, Henan Physiological Society
Vice Chair, Professional Committee on Neurobiology
Standing Council Member, Henan Society of Biochemistry and Molecular Biology
Member, Chinese Society of Biochemistry and Molecular Biology
Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Diseases, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, ChinaProtein Medications; Carcinogenesis; Treatment
Professor, Guangzhou Medical University, GuangZhou, China
Deputy Director, Guangdong Provincial Key Laboratory of Protein Modification and Degradation
Council Member, Chinese Pharmacological Society
Standing Council Member, Guangdong Pharmacological Society
Secretary, Specialized Committee on Protein Modification and Disease, Chinese Society of Pathophysiology
Vice Chair, Specialized Committee on Drug Screening and Evaluation, Guangdong Pharmacological Society
1. Biobank of Research, IRCCS Azienda Ospedaliera-Universitaria di Bologna Policlinico di S. Orsola, Bologna, Italy;
2. Department of Medical and Surgical Sciences, Alma Mater Studiorum Università di Bologna, Bologna, ItalyLeukemia; Lymphoma; Targeted therapy; Molecular diagnostics; High throughput genomics; Transcriptomics; Digital pathology
Associate Professor of Pathology & Executive Physician, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy
Adjunct Professor of Hematology and Pathology at Jomo Kenyatta University of Agricolture and Technology, Nairobi, Kenya
Member of the Scientific Committee, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
National Academic Qualification as Full Professor of Pathology
Associate Editor for the American Journal of Blood Research, Modern Chemotherapy, World Journal of Hematology, Frontiers in Molecular Biosciences, Helyon.
Member of the SIE, SIES, ASH, AACR, SIAPEC/IAP, EHA, ELN/EWALL, FIL
Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, ItalyWound Healing; Vascular Surgery; Metabolic Syndrome; Treatment; Vascular Medicine; Reconstructive Surgery; General Surgery; Surgery; Diabetes; Atherosclerosis
Associate Professor of Vascular Surgery at the University Magna Graecia of Catanzaro, Catanzaro, Italy
Full Professor of Surgery and Vascular Surgery
Academic Head of Calabria Region of Italian Society of Vascular and Endovascular Surgery (SICVE).
"International -1- Member" of the Association for Academic Surgery (AAS).
Holder of “Zaleuco” Prize for Vascular Surgery conferred by Associazione Cenacolo della Cultura e delle Scienze
Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, United StatesDiabetes; Redox Biochemistry; Mitochondrial Oxidative Stress; Acute Kidney Injury; Chronic Kidney Disease
Professor of Pharmaceutical Sciences
Top 2% Worldwide Scientists in the 2024 Edition of Stanford University/Elsevier ranking
Director for a Journal Club Course
Member of American Society for Biochemistry and Molecular Biology
Member of Society for Redox Biology and Medicine
Member of the International Society of Nephrology
Member of the International Society of Neurochemistry
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBasic and clinical applications of tumor immunotherapy and cell therapy
Director and Professor, Zhengzhou University, China
Recipient of the State Council Special Allowance, China
Academic Vice President, Medical School, Zhengzhou University
Chief Scientist, The First Affiliated Hospital of Zhengzhou University
Director, Biotherapy Center and Division of Bioimmunotherapy, The First Affiliated Hospital of Zhengzhou University
Member, European Society of Immunology (ESI); American Association for Cancer Research (AACR); American Association of Immunologists (AAI)
Council Member, Chinese Society of Immunology
Chair, Professional Committee on Biotherapy, Henan Anti-Cancer Association & Henan Society of Immunology
Executive Vice Chair, Cell Therapy Quality Management and Research Branch, China Quality Management Association for Pharmaceuticals
Vice Chair, Biotherapy Branch, Chinese Society of Research Hospitals
Standing Council Member, Committee on Tumor Immunotherapy, Chinese Anti-Cancer Association (CACA)
Committee Member, Immuno-Oncology Committee, Chinese Society of Clinical Oncology (CSCO)
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”,Naples, ItalyCellular Senescence; Radiation Therapy; Stem Cells; Cell Cycle
Member of Stem Cell Research Italy (SCR Italy)
Postdoctoral fellowship in Molecular Biology at the School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
Young Researcher at Human Health Foundation Onlus. Philadelphia, PA, USA (2007/2008)
Researcher at CNR (National Research Council), Napoli, Italy (2012/2013 )
Postdoctoral fellowship at University of Campania, Napoli, Italy (2013/2017)
Visiting Researcher at CNIO, Madrid, Spain (2013)
Visiting Researcher at GENEKOK, Kayseri, Turkey (2014)
Visiting Researcher at Tohoku University, Sendai, Japan (2015)
Visiting Researcher at CEA, Fontenay-aux-Roses, France (2017)
Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, ItalyAcute Kidney Injury; Renal Failure; Nephrotoxicity; Experimental Nephrology
Full Professor of Nephrology at the Department of Health Sciences, "Magna Græcia" University, Catanzaro, Italy.
Awarded at several national and international nephrology congresses. Prof. Andreucci has more than 200 publications in international, peer-reviewed scientific journals with an h index factor of 42 and more than 5100 citations to his work
Department of Life and Environmental Sciences, Marche Polytechnic University, Via Brecce Bianche, Ancona, ItalyLipoproteins; Antioxidant Activity; Reactive Oxygen Species; Inflammation; Oxidative Stress; Metabolic Syndrome; Antioxidants;Nutrition; Cardiology; Atherosclerosis
Prof. Bachetti currently works at the Laboratory of developmental Neurobiology, University of Genova, Italy and in UOSD Laboratory of Genetics and Genomic of Rare Diseases in IRCCS Istituto G. Gaslini, where she have worked several years. Her main research field is molecular genetics of neurodevelopmental disorders.
Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, United StatesPsychiatry; Neuroimaging; Molecular Imaging; Addiction Psychiatry; Cognitive; Memory; Consciousness; Brain; Prefrontal Cortex; Genetic Addiction Risk Severity
Professor and Chief of Psychiatry at the VA at The University of Texas Health Science Center at San Antonio.
Prof. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.
Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Firenze, Firenze, ItalyThrombosis; Fibrinogen; Oxidative Stress; Protein Structure
Department of Chemistry, Cleveland State University, Cleveland, United StatesCancer Chemotherapy; DNA Damaging Agents; DNA Polymerases; Nucleoside Analogs; DNA Repair; DNA Damage Response; Leukemia; Glioblastoma Multiforme
Professor, Department of Chemistry, Cleveland State University, Cleveland, United States.
Prof. Anthony J. Berdis is a biochemical and chemical biology researcher with expertise in DNA replication, DNA repair, nucleotide metabolism, medicinal chemistry, and cancer therapeutics. His research focuses on the design, synthesis, and biological evaluation of non-natural nucleosides and nucleotides as therapeutic and diagnostic agents targeting DNA polymerase activity.
Prof. Berdis’s laboratory investigates how DNA polymerases replicate normal and damaged DNA, with particular emphasis on translesion DNA synthesis, genomic fidelity, and mechanisms of resistance to DNA-damaging anticancer agents. His work has contributed to the development of artificial nucleoside and nucleotide analogs that can serve as probes for polymerase activity and as potential agents for enhancing the efficacy of cancer therapies.
His research spans chemistry, biochemistry, molecular oncology, pharmacology, and drug discovery. Through studies on DNA damage responses, polymerase selectivity, nucleoside analog development, and cancer cell sensitivity to chemotherapeutic agents, Prof. Berdis contributes to the advancement of mechanism-based strategies for cancer diagnosis, treatment, and therapeutic optimization.
Department of Biomedicine, Neuroscience and advanced Diagnostics (BIND), University of Palermo, Palermo, ItalyBrain Stimulation; Cognitive Sciences; Headaches and pain; Neuromuscular Diseases
Associate Professor of Neurology of University of Palermo, Palermo (UNIPA) .
Prof. Brighina MD, board certified neurologist, associate professor of neurology at University of Palermo, Italy, chief of the Center for the Study of the Headaches, rhe center for the study of rare neuromuscular disease and the Unit of Neurophysiopathology (clinical electrophysiology,and non invasive brain stimulation techniques) at the University Hospital Policlinico of Palermo, Italy.
Principal research interests: headache and clinical neurophysiology with particular respect to techniques of not invasive brain stimulation like transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES), applied to explore pathophysiology and also potential alternative treatment strategies of neurological and psychiatric diseases. Filippo Brighina performed NIBS studies on neglect, aphasia, chronic pain but the principal target of his research, especially in last years was migraine. He particularly explored pathophysiological mechanisms specifically investigating the role of abnormal cortical excitability as a critical factor underlying attacks precipitation and chronification of the disease.
More recenly, his interest moved also to rare neuromuscular diseases with particular reference to treatable rare genetic disease (hereditary transtiretin amiloidosis).
He authored 198 publications on ISI journal and presented about 200 papers at national and international meetings; he has been member of the executive board of the Italian Society for the study of Headache (SISC) and Italian Society of Psychophysiology (SIPF). He is also member of the editorial board of the following journals: Frontiers in Human Neurosciences, Pain Research and Management (associate editor), BMC neurology (associate editor), Brain Science (associate editor). He’s also ad hoc referee of many scientific high impact ISI journals (Brain, Cephalalgia, Cerebellum, Clin Neurophysiol, Europ J Neurosci, Headache, J Pain, J Neurosci, Cortex, Neuropsychologia, Pain etc) and performed reviews of research project for MIUR (Ministry of Italian University and Research) and SNSF (Swisse National Science Foundation).
1. Klinisk Genetik, Vejle Sygehus, Department of Clinical Genetics, Lillebaelt Hospital,Vejle, Denmark;
2. Institute for Regional Health Services, University of Southern Denmark, Odense, DenmarkMolecular Genetics; Molecular Biology
Professor, IRS - Lillebælt Hospital, Research Unit of Human Genetics (Vejle)
Founder of Amplexa Genetics A/S
Senior researcher, Department of Clinical Genetics, Odense University Hospital, Odense.
Associate professor, Institute of Health, University of Southern Denmark
Visiting Professor, Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Cyprus
Editor on PlosOne (more than 100 manuscripts) and Advances in Endocrinology, ContROL– Genetics
Review for PlosOne, Lipidology, European Journal of Endocrinology, SciTechnol, BioMed Central, Clinical Biochemistry, Frontiers in Genetics, Clinical Biochemistry, Frontiers in Genetics, SciTecTool.
Member of the National Genom Center Advisory board on Endocrinology, EndoGenNet.
Member of the National Genom Center Advisory board on interpretation.
CRN Genetics Workstream and CRN Council, the CHI Collaborative Research Network (CRN)
Member of Illumina sequencing expert panel, Nordic Alliance for Clinical Genomics (NACG), Danish Sociaty of Clinical Academics (DSKA), Danish Sociaty of Clinical Genetecist (DSMG), Odense Pancreas Center (OPAC)
Imperial College London, Department of Surgery and Cancer, London, United KingdomNon-coding; Transcription; miRNA; lncRNA; Cancer Regulation
Dr Leandro Castellano obtained his Master Degree in Biology in Biology at the University of Salento, Italy. He then moved to Rome at the University “La Sapienza” where he completed a PhD in Human Biology and Genetics (2003-2007) working during the first year on the role of Post Transcriptional Gene Silencing (PTGS) in the Circadian Rhythm of the filamentous fungus Neurospora Crassa and later, on the role of microRNAs in human Cell Cycle and in Chronic Lymphocytic Leukaemia (CLL).
He moved to Imperial College London in 2007 where he worked as a Research Associate focusing on the role of microRNAs in epithelial cancers. From 2011 he was appointed as Team Leader at the Division of Surgery and cancer, at Imperial, where he directly supervised several PhD students, Research Associates and Research Assistants. During these years Dr Castellano research interests expanded from microRNAs to the role of various classes of short and long non-coding RNAs in epithelial cancer development and progression.
He is the Head of Department of Biochemistry and Biomedicine and a Reader (Associate Professor) in RNA Biology at the University of Sussex and holds an honorary position at Imperial College London as visiting Reader.
He is the co-Director of the Sussex RNA Research Centre (https://www.bsms.ac.uk/research/clinical-and-experimental-medicine/rna-biology-research-group/index.aspx)
He is the Designated Individual (DI) under the Human Tissue Act at the School of Life Sciences at the University of Sussex.
He is a fellow of the higher education academy (FHEA).
For more information about our research see the Castellano Lab website:
https://www.sussex.ac.uk/research/labs/castellano-lab/
Editorial Board
- Associate Editor, “Oncogene” (Springer Nature)
- Associate Editor "Cancer Gene Therapy" (Springer Nature)
- Editorial Board "Non-coding RNA" (MDPI)
- Editorial Board, “Non-coding RNA Research” (KeAi publishing, Elsevier)
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.Genomics; Proteomics; Drug repurposing; Bioinformatics; Next-generation sequencing; Cancer biomarker; Evidence-based medicine; Extracellular vesicles; MicroRNA; Molecular diagnostics; Non-coding RNAs; Nasopharyngeal carcinoma; Non-small cell lung cancer
Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.
Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, ChinaNano Functional Materials; Nano Image Probes; Intelligent Diagnosis and Treatment Instruments; Gastric Cancer Early Warning and Early Theranostics System; Nano Therapy Technology Development and Transformation
Distinguished professor of Shanghai Jiaotong University, Shanghai, China.
Dr. Cui is currently a distinguished professor of Shanghai Jiaotong University, vice dean of Translational Medicine Research Institute of Shanghai Jiaotong University, the head of the Nano-Biotechnology Research Institute, Assistant Dean of the Institute of Micro-and Nano-technology, PhD supervisor, Deputy Director of the key laboratory of thin-film micro-technology, winner of the National Fund for distinguished young scholars, and Chief Scientist of Nano major scientific research projects. His research fields are nano-material synthesis, biological effects and safety evaluation, multifunctional nano-probes and molecular imaging.
Department of Pharmacy, University of Pisa, Pisa, ItalyIntracellular Pathways; Epigenetic Regulation; Neurodegenerative Disease-related Proteins
Associate Professor in Molecular Biology at the Dept. of Pharmacy, University of Pisa, Italy.
Dr. Simona Daniele (SD) is an associate professor in Molecular Biology at the Dept. of Pharmacy, University of Pisa, Italy. She gained a Phd in Science of Drug and Bioactive Substances in 2011. From 2012 to 2016 she won Post-doc positions in Biochemistry and Molecular Biology at University of Pisa, University of Milan and at the Italian Institute of Technology. From 2016 to 2019, she worked as a senior researcher in Molecular Biology at University of Pisa.
The research activity is proven by more than one hundred papers published in prestigious international journals, mainly dealing with intracellular pathways and protein aggregation. SD has had the opportunity to work in laboratories in Pisa, Genoa, Milan, Barcellona and Bethesda where she has mastered a number of different biological and cellular techniques.
From 2009 to present, SD has been involved in several projects concerning molecular and intracellular signalling pathways related to neurodegenerative and neurodevelopmental diseases, as well as in the molecular characterization of innovative drugs. She has developed and set-up of immunoenzymatic assay to detect protein hetero-complexes, including p53 ones, and protein aggregates. She has a great expertise in the development of biological tests for target-verifying of new compounds, cell culture, isolation of stem cells from cell lines and tissues, stem cell differentiation and study of intracellular pathways. In the last years, she has developed new skills in managing biological samples derived from patients and in analysing clinical data.
Department of Pathology, National University of Singapore, SingaporeCancer Immunotherapy; Targeted Therapy; Cancer Vaccine; Cancer Genome; cfDNA Methylome and Cancer Screening
Research Assistant Professor in the field of Pathology.
The research interests of the applicant focus on two critical areas in cancer research: developing innovative therapeutic approaches to overcome resistance to cancer immunotherapy; and identifying genetic and epigenetic abnormalities in cancers and pre-cancers. He has authored 71 manuscripts in international journals, over half of them were published in journals with impact factor >10. He also served as an invited ad hoc reviewer and reviewed over 440 manuscripts for 131 international journals. Over the past two years, he has successfully secured more than 2.2 million SGD in research funding as the Principal Investigator (PI), and 3.5 million SGD as Co-Investigator and Collaborator. He also contributes as a Team Principal Investigator to a large CRP (Competitive Research Programme) grant from NRF. He was the recipient of the prestigious Lee Kuan Yew Postdoctoral Fellowship and the Year 2021 Gilead Research Scholars Award (Hematology and Oncology).
Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, Bucuresti, RomaniaIschemic Heart Disease; Atherosclerosis; Molecular Mechanisms of Acute coronary Syndromes; Arterial Hypertension; Hypertensive Target Organ Damage
Maria DOROBANTU, MD, PhD, FESC, FACC Emeritus Professor at the University of Medicine and Pharmacy Carol Davila Bucharest Past Chair of the WG6 of ESC (Chair 2016-2018) Ex officio member of the Board of ESH, (Representative with National Societies) from 2019 Member of the ESH Board as a Representative of the National Societies of Hypertension (2019-2021 ) President of ISH RAG Europe(since 2024) Corresponding Member of the Romanian Academy Associate Member of National Academy of Medicine, France Member of the Romanian Academy of Medical Sciences Member of the Academia Europaea My special fields are Microcirculation, ACS and Hypertension Publications in these fields in EHJ, IJC, JH, Lancet, NEJM, Echocardiogragy, RJC, JHR, etc Books in Springer Publishing House as co-edithor (Hypertension and HF, Microcirculation, New Insights in HF, etc) in Romanian Academy Publishing House (5 books one awarded with the Romanian Academy Prise) Medical Publishing House, etc HIRSCH Index 46 (21,113 citat
Nutrigenomics and Growth Biology Laboratory, Washington State University, Pullman, United StatesNutrigenomics; Stem cell; Adipose and Muscle Development; Obesity and Diabetes; Exercise
Regents Professor and Endowed (Funded) Chair in Nutrigenomics and Growth Biology, Department of Animal Sciences, Washington State University, Pullman, WA.
AWARDS, HONORS AND OTHER EXPERIENCES:
- Elected to the Washington State Academy of Sciences, 2024.
- Regents Professor, Washington State University, 2023-Current.
- The American Society of Animal Science (ASAS) Award in Animal Physiology and Endocrinology, 2019.
- Faculty Excellence in Research Award, College of Agricultural, Human, and Natural Resource Sciences, WSU, 2018.
- The American Society of Animal Science (ASAS) Award in Animal Growth and Development, 2017.
- Distinguished Service Award, Physiological Genomics Group, American Physiological Society, 2017.
- Standing Member, NIH-NIDDK, (Diabetes, Endocrinology, and Metabolic Diseases B, DDK-B) Study Section (2016-2020).
- Fulbright Specialist, Institute of International Education (IIE), the U.S. Department of State, Washington, DC. 2016-2021.
- Ad hoc Member, NIH-NIAMS, Special Emphasis Grant Review Panel (ZRG1), 2009-2017.
- Invited Speaker, the Celebration of Science Week, Purdue University, West Lafayette, IN, May 9 -11, 2012.
- Early Career Achievement Award, American Society of Animal Science, 2010.
- Outstanding Advisor Award, College of Agriculture, University of Wyoming, 2008.
- Young Scientist Award, Western Section American Society of Animal Science, 2008.
- Research Award, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, 2007.
- Research Career Enhancement Award, American Physiological Society, 2006.
- Postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC), 2001.
- Research Excellence Award, Graduate College, Iowa State University, 2001.
- Thomas Sutherland Graduate Award for Excellence, Department of Animal Science, Iowa State University, 2001.
- Wilma D. Brewer Award for Excellence in Scientific Writing, Department of Food Science & Human Nutrition, Iowa State University, 2001.
- Verba S. And Verner H. Nielsen Scholarship Fund, Department of Food Science & Human Nutrition, Iowa State University, 2001.
- Member of national honor society of agriculture, USA: GAMMA SIGMA DELTA.
- David R. Griffith Research Excellence Award, Nutritional Sciences Council, Iowa State University, 2000.
- Ned S. & Esther Raun Graduate Scholarship, Department of Animal Science, Iowa State University, 2000.
- Ensminger Scholarship, Department of Animal Science, Iowa State University, 1999.
Mazandaran University of Medical Sciences, IranStem Cell-biotechnology; Medical Biotechnology; Regenerative Medicine; Cell Therapy
Assistant Professor of Medical Biotechnology, Mazandaran University of Medical Sciences.
Dr. Enderami currently works at Mazandaran University of Medical Sciences. Their current projects are 'Pancreatic tissue engineering' and wound healing.
1.Lomonosov Moscow State University, Moscow, Russia;
2.Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, RussiaNucleosome Structure; Nucleosome-Protein Interactions; Single Molecule; spFRET Microscopy
Professor Alexey V. Feofanov is affiliated with Lomonosov Moscow State University, Moscow, Russia and Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Dr. Feofanov's research interests include Nucleosome Structure, Nucleosome-Protein Interactions, Single Molecule, and spFRET Microscopy. Dr. Feofanov contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 36, indicating a sustained record of scholarly output and citation impact.
International Head and Neck Scientific Group, Padua, Italypromotion of international cooperation in head and neck surgery, oncology and cancer research.
Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.
Dr. Alfio Ferlito received many honors and awards during his career. He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.
School of Pharmacy, University of Camerino, Camerino (MC), ItalyEpigenetics and Neurodegeneration; Nutrigenomics; Xenobiotics and Redox System
Full Professor of Biochemistry, University of Camerino, Italy.
Prof. Rosita Gabbianelli is Full Professor in Biochemistry (BIO/10, Biochemistry) at University of Camerino, Italy from June 2021. She teaches Molecular Biology and Nutrigenomics at the Bachelor degree Course and Master degree course of Chemistry and Pharmaceutical Technology of Faculty of Pharmacy in UNICAM, Italy. Invited professor of Biochemistry at the Jilin Agricultural University, Changchun, China (from 2015). Invited Professor in Nutrigenetics and Nutrigenomics, at the University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Department/Unit of Food Science, CLUJ-Napoca, Romania (from 2015) and at ISS-ISEP, Porto, Portugal. Teaching activity on Nutrigenomics at University of Pharmacy-Hanoi, Vietnam, Quy Nhon University, Vietnam and Pemba, Tanzania (2017).
Prof. Rosita Gabbianelli cooperates as Guest Editor of Antioxidants, J Nutrigenet Nutrigenomics, Mech Ageing Dev, and she is a Member of review panels of several journals on health. She is Reviewer of theEuropean Commission (EX2006C200916) H2020-SC1-2019-SINGLE-STAGE-RTD, the Reprise - Register of Expert Peer Reviewers For Italian Scientific Evaluation, the STSM Cost Action NutRedOx and the Czech Science Foundation. She is Italian MC Member of DEVoTION CA18211 and HyperChildNET CA19115, and Action participant in NutRedOx CA16112 and Epichembio CM1606. Prof. Rosita Gabbianelli is the Chair of the Scientific and Organizing Committee of the European Summer School on Nutrigenomics (from 2014).
Her research field includes the study of genetic and epigenetic mechanisms associated to the development of neurodegeneration induced by early life exposure to food pesticides and nutrigenomic strategies to counterbalance neuronal damage. Her expertise is documented by 118 peer-reviewed publications, 4 book chapters and 133 abstracts to international meetings.
Amsterdam UMC - University of Amsterdam, Amsterdam, NetherlandsAdvanced molecular cancer diagnostics and cell and gene therapy, molecular cancer research
Medical biologist with a career in clinically important cancer research. Scientific knowledge ranging from fundamental to clinical topics, therapy development, and diagnostics. Industry experience in research, development, manufacture, and QA/QC. Specialized in novel technologies, high-throughput analyses and screens, lead prioritization, and validation.
Aristotle University of Thessaloniki, School of Pharmacy, Thessaloniki, GreeceBiologically Active Heterocycles; Thiazole; Thiazolidinone; Benzohiazole; Thiadiazoles with Antimicrobial Activity; COX/LOX; PTP1b; HIV RT Enzyme Inhibitors; Antiinflammatory
Associate Professor, Aristotelian University of Thessaloniki Greece.
Natural Products of Uzbek Academy of Science. In 1977 she defended her PhD thesis and received the Ph.D grade in Chemistry (Ph.D, Doctor of Philosophy in Chemistry). In 1984 she graduated from the School of Pharmacy of Aristotle University of Thessaloniki. From 2006-2013 she served as Head of the Department of Pharm.Chemistry. Since 2010 she has been Full Professor on Medicinal Chemistry for School of Pharmacy at Aristotle University of Thessaloniki. During 2009-2011 she was Vice President of School of Pharmacy at Aristotle University of Thessaloniki.In July 2013 Prof.Geronikaki was elected as a Full member of the Mediterranean Academy of Science and Arts.Her scientific interest is Chemistry of natural products isolation, determination of the structure; Chemistry of biologically active compounds and evaluation of their activity, using different computational methods.
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata, ItalyNatural product; Cancer; Oxidative stress biomarkers; Modulatory action of nuclear receptors; Adipokines in the development and progression of breast cancer
Professor Francesca Giordano is affiliated with Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata, Italy.
Dr. Giordano's research interests include Natural product, Cancer, Oxidative stress biomarkers, Modulatory action of nuclear receptors, and Adipokines in the development and progression of breast cancer. Dr. Giordano contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 31, indicating a sustained record of scholarly output and citation impact.
Department of Drug Design, University of Groningen, Antonius Deusinglaan, Groningen, The NetherlandsStructural Biology; Biocrystallogenesis; Infectious Diseases; Drug Design; Biophysics
Associate Professor at the Department of Drug Design, University of Groningen.
Dr. Groves received his Honours Degree in Physics from Worcester College, Oxford University, and gained his PhD from the University of London in 1999 under the supervision of Prof Tom Blundell. After post-doctoral experience in Oxford and EMBL, Heidelberg. He was appointed as an independent staff scientist at EMBL Hamburg. In 2013, he moved to the Groningen Research Institute for Pharmacy, University of Groningen and is now an associate professor. He is currently responsible for the "Medicinal Chemistry and Biophysics" course and is also involved in a Masters's program in "Molecular Medicines and Innovative Therapies" as a lecturer. His teaching disciplines include crystallography, biophysics, and infectious diseases. His research interests include structure-based drug design in human diseases, using structural, biochemical, and molecular biology to investigate disease-relevant pathways in cancer, malaria, and tuberculosis.
Jonsson Comprehensive Cancer Center, California Nanosystems Institute, Division of Oral and Systemic Health Sciences, School of Dentistry, University of California, Los Angeles, United StatesCancer; Biochemistry; Genetics and molecular Biology; Cancer metabolomics/proteomics; Cancer stem cells; Sjogren’s syndrome; Burning mouth syndrome and chronic pain
Professor at University of California, Los Angeles, United States.
Dr. Hu is a Professor and was previously the MS Program Advisor in the Division of Oral and Systemic Health Sciences at the UCLA School of Dentistry. He has managed the Oral Biology MS program since 2011. Dr. Hu is also a member of the UCLA Jonsson Comprehensive Cancer Center (JCCC) and currently serving as an editorial board member for multiple international journals. He recently edited the Cancer metabolomics: Methods and Applications for Springer Advances in Experimental Medicine and Biology book series.
Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, IranGenetics and Molecular Epidemiology; Cancer Biology; Epigenetics in Epidemiology; Cell Signaling; Virology; Genomic Surveillance in Public Health; Biomarker Development; Animal Models; Drug Discovery
Researcher, Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Kiavash Hushmandi is a researcher with academic interests in urological diseases, cancer biology, molecular oncology, and translational therapeutic strategies. His research focuses on the molecular mechanisms of cancer progression, tumor microenvironment remodeling, cancer immunotherapy, and emerging therapeutic approaches for urological and hematological malignancies.
His recent work has addressed topics including kidney, bladder, and prostate cancers, bispecific antibodies, CAR-T cell therapy, cancer vaccines, drug delivery systems, nanomedicine-based therapeutic strategies, and molecular pathways involved in disease progression. He has also contributed to studies in public health, cancer epidemiology, renal disease, diabetes-related mechanisms, and cardiorenal therapeutic targets.
Through interdisciplinary research spanning oncology, nephrology, urology, molecular medicine, and pharmacological therapeutics, Kiavash Hushmandi contributes to the understanding of gene- and protein-related disease mechanisms and the development of innovative approaches for disease diagnosis, prevention, and treatment.
Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, BangladeshCancer Biology; Cancer Molecular Marker; Gastrointestinal Cancers; Cancer Drug Development; Cancer Genetics, Epigenetics; Cancer Signaling
Professor in the Department of Biochemistry and Molecular Biology, University of Rajshahi, Bangladesh.
Dr. Islam has completed his undergraduate studies and MPhil in biochemistry and molecular biology at Rajshahi University, Bangladesh, and then completed his PhD in Cancer Molecular Pathology at Griffith University in the School of Medicine. Dr Islam is working on cancer biology, drug development and delivery, molecular marker development for various cancer. His has published more than 50 peer-reviewed research articles in well-reputed journals. He also wrote and published more than 7 book chapters on cancer pathogenesis and protocols with reputed publishing outlet e.g. Springer, Elsevier.
Dr. Islam was recently awarded the Chancellor's Medal for Excellence in the PhD Thesis for 2018, in recognition of his exceptional performance. He is also awarded Dean’s Award 2019, Faculty of Science, University of Rajshahi, Bangladesh for outstanding achievement in research. Dr Islam is currently working as a Post-Doctoral Research Fellow this Institute. He is also an Associate Professor (on leave) in the Department of Biochemistry and Molecular Biology at the University of Rajshahi in Bangladesh.
1. CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, India;
2.Department of Biochemistry, Kakatiya Medical College, Warangal, IndiaAlzheimer's Disease; Diabetes Mellitus; Neuronal Trafficking; Therapeutic Biomolecules; COVID-19
Assistant Professor (Res.) at the Texas Tech University of Health Sciences Center (TTUHSC), Lubbock, TX, USA. Dr. Kandimalla obtained his Ph.D. in Neuroscience from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Dr. Kandimalla received postdoctoral fellowships from McGill University, Montreal, Canada; Emory University, Atlanta, USA and Oregon Health Sciences University, Portland, USA. Dr. Kandimalla worked to develop new animal models of schizophrenia that take into account the purported neurodevelopmental features of the disease including its clinical manifestation following the onset of puberty under the super vision of Dr. Remi Quirion at McGill University. At Emory University under the supervision of Dr. Huichen Wang, Dr. Kandimalla work focused on the mechanism of ionizing radiation (from high energy particles during space mission (NASA)-induced DNA double strand break repair in the central nervous system. Dr. Kandimalla found that radiation increased the neuronal progenitor cell death and reduced neuronal plasticity. Dr. Kandimalla work demonstrated inhibition of GSK3β in protecting neural cells from DNA damage and oxidative stress induced by x-ray, proton and high energy charge particles radiation. In addition, Dr. Kandimalla investigated the effect of amyloid beta on radiation induced DNA damage response in neuronal cells. Dr. Kandimalla got extensive training on the DNA damage response, neuronal stem cell, and neuronal plasticity. Along with this main project Dr. Kandimalla also worked on several of types of DNA repair mechanisms (by using engineered plasmids) in breast cancer and brain tumor. Dr. Kandimalla has shown lot of interest on latest advances in neuroscience like optogenetics, Knock-in / Knock-out Mouse via Cas9-CRISPR technology, Axonal guidance mechanisms, neuronal morphology by an advanced immunochemical technique, and cellular mechanisms of cognition by electrophysiology. Dr. Kandimalla writing skills are highly commendable and have very good teaching skills (Co-Mentored EMORY SURE PROGRAM Student). Dr. Kandimalla involved in Dr. Hemachandra Reddy (2) NIH R01 grants – Dynamin-related Protein 1 and Mitochondrial Fragmentation in Alzheimer’s disease (AG042178) and Voltage-dependent Anion Channel Protein 1 and Neurodegeneration in Alzheimer’s disease (AG047812). Currently Dr. Kandimalla primary focus is on maintaining mouse colonies, including heterozygote knockouts of dynamin-related protein 1 and voltage-dependent anion channel 1, and transgenic lines of amyloid precursor protein and mutant tau mice. He created double mutant lines (Tau X Drp1+/-; APP X Drp1+/-; Tau X VADC+/- and APP X VDAC1+/-) and involved with characterizing for mitochondrial structure/function, synaptic activity and amyloid beta and tau pathologies. Dr. Kandimalla uses multiple techniques and approaches, including molecular biology and cell biology, cell culture and light/fluorescence/confocal microscopies. Dr. Kandimalla is author and/or co-author for more than 35 peer-reviewed articles. Dr. Kandimalla is also reviewer and editor for various neuroscience and biochemistry journals.
Cancer Biology Laboratory & DBT-AIST International CENter for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Guwahati, Guwahati, IndiaInflammatory Pathways and Chronic Diseases; Cancer Biology and Therapeutics
Professor, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati.
Major research work accomplished at IITG so far:
Institute of Transfusion Medicine and Immunology, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Heidelberg, GermanyInnate Immunity; Immunometabolism; Cancer Immunology; Diabetes; Regeneratvie Medicine
Professor of Cell and Moleculr Biology, University of Heidelberg.
Prof. Kzhyshkowska currently works as a Professor, and the Head of the Department for Innate Immunity and Tolerance at the University of Heidelberg. She mainly focuses on cell biology, inflammation, scavenger receptor, molecular biology, and immunology. Her cell biology research is multidisciplinary, incorporating perspectives in cell surface receptor and nucleotide excision repair, DNA repair protein XRCC4, and homology-directed repair. She studied inflammation and cytokines that intersect with proinflammatory cytokines, implant failure, and implant interaction with host and ex vivo. The various areas that she examines in her molecular biology study include receptor, DNA repair, and interleukin 4. Much of her study explores immunology's relationship to macrophages. Her macrophage research is multidisciplinary, incorporating elements of adipose tissue macrophages and pathogenesis and pathology.
Department of Psychiatry, China Medical University, Taichung, TaiwanPharmacogenomics; Psychiatric genetics; Neuropsychopharmacology; Cognitive neuroscience; Schizophrenia; Clinical Psychiatry
Professor Hsien-Yuan Lane is affiliated with China Medical University and Hospital. His academic work is related to biomedical research, molecular medicine, and disease-oriented life science. He contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 55, indicating a sustained record of scholarly output and citation impact.
1. Sperimental and Clinical Medicine Department, Faculty of Medicine, University of Foggia, Foggia, Italy
2. Biomedical Center, Applied Physics Laboratory, Via Napoli 20 c/o OO.RR. Foggia, ItalyEnvironmental Toxicology; Ecotoxicology; Cancer Diagnostics, Raman MicroSpectroscopy, FTIR Spectroscopy, Immunofluorescence Microscopy, Material Characterization; Atomic Force Microscopy
Associate Professor in Applied Physics at university of Foggia, Foggia, Italy.
Dr. Maria Lasalvia is currently working as Official Biologist at University of Foggia, Applied Physics Laboratory. She obtained her Ph.D. in Biology from same University. Her main area of interest related to Pharmacology and Toxicology, Biomedical Sciences, Molecular Sciences, Physical Science Engineering, and Environmental Sciences. Her area of expertise includes Biological Research, RAMAN Micro Spectroscopy, Atomic Force Microscopy, Pesticides, Occupational Safety and Health, Cells Culture, Cells Viability Test, FTIR (Fourier Transform Infrared Spectroscopy), Fluorescence Microscopy, Live Cells Analysis, Blood Analysis, Analytical Techniques for Chemical Analysis, and Protein Biochemistry Techniques. She has published 74 research articles in journals and conferences as author/co-author.
Department of traslational medicine, University of Ferrara, Ferrara, ItalyOral Medicine and Biology; Pediatric Dentistry; Molecular Biology of the Oral Cavity; Microbiology of the Oral Cavity in Leukemic Pediatric Patients: PCRealtime Study; Neurophysiological Study of Peripheral Neuropathies of the Oral Cavity; MAPkinases in the Precancerous Lesions of Oral Mucous Membranes
Professor Dorina Lauritano is affiliated with Department of traslational medicine, University of Ferrara, Ferrara, Italy.
Dr. Lauritano's research interests include Oral Medicine and Biology, Pediatric Dentistry, Molecular Biology of the Oral Cavity, Microbiology of the Oral Cavity in Leukemic Pediatric Patients: PCRealtime Study, and Neurophysiological Study of Peripheral Neuropathies of the Oral Cavity. Additional areas listed in the board record include MAPkinases in the Precancerous Lesions of Oral Mucous Membranes. Dr. Lauritano contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 58, indicating a sustained record of scholarly output and citation impact.
Center For Advanced Spinal Surgery, Tucson, AZ, United StatesOrthopedic Surgeons Diagnose; Treat Ailments affecting Muscles; Bones and Joints; Treating Sports Injuries; Degenerative Diseases; Tumors; Infections; Birth Defects
Dr. Kaiuwe Lewandrowski is an orthopedist in Tucson, Arizona and is affiliated with Carondelet St. Mary's Hospital, El Dorado Surgery Center-Tucson and Surgical Institute of Tucson. He received his medical degree from Humboldt University of Berlin- Charite Faculty of Medicine and has been in practice for more than 20 years. Dr. Kaiuwe Lewandrowski has expertise in treating spinal fusion, spinal stenosis and spondylosis, among other conditions - see all areas of expertise. Dr. Kaiuwe Lewandrowski accepts Medicare, Aetna, Humana, Cigna, Blue Cross, United Healthcare - see other insurance plans accepted.
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaMulti-omics; Immune Microenvironment; Metabolism Biotherapeutic Targets; Clinical Prediction Model; Disease; Artificial Intelligence Technology
Dr. Li practices in Zhengzhou, China. Their top areas of expertise are Ectopic Pregnancy and Lewy Body Dementia (LBD).
Their clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Bristol Myers Squibb, Princeton, United StatesCell Culture; PCR; Western Blot Analysis; Gel Electrophoresis; Cancer Biology; Electrophoresis; DNA Extraction; Cloning; DNA; SDS-PAGE
Director, Bristol Myers Squibb, United States.
Dr. Yan Li is a pharmaceutical scientist with expertise in clinical pharmacology, pharmacometrics, and model-informed drug development. Dr. Li’s research focuses on population pharmacokinetics, pharmacokinetic/pharmacodynamic modeling, exposure–response analysis, and quantitative approaches to support dose optimization and drug development decision-making.
Dr. Li has contributed to pharmacometric and clinical pharmacology studies in oncology and hematology, including research on immunomodulatory and cereblon-modulating agents, population pharmacokinetic modeling, renal impairment assessment, drug disposition, and quantitative strategies for clinical development. Dr. Li’s recent work also includes the application of advanced computational and machine-learning methods to longitudinal PK/PD analysis.
With industry experience at Bristol Myers Squibb, Dr. Li contributes to translational and clinical development programs by integrating pharmacokinetic, pharmacodynamic, biomarker, and clinical data to inform evidence-based drug development, therapeutic optimization, and regulatory-supportive analyses.
Stem Cell and Biotherapy Engineering Research Center of Henan Province, Xinxiang Medical University, Xinxiang, ChinaStem Cells; Neural System Diseases; blood; Gene-modified
Guest Researcher at the Department of Anatomy, Faculty of Medicine, Friedrich Schiller University Jena, Germany; Part-time Researcher at Universiti Sains Malaysia (USM).
Member of the European Neuroscience Association, Director of the Henan Society for Cell Biology, and Chair of the Stem Cell Specialty Committee.
Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, New York, United StatesAlzheimer’s Disease; Down Syndrome; Neurodegeneration; Tau; Alternative Splicing; Phosphorylation; Kinase; Phosphatase; TDP-43; Truncation; O-GlcNAcylation; Propagation of Tau Pathology
Professor Fei Liu is affiliated with Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, New York, United States.
Dr. Liu's research interests include Alzheimer’s Disease, Down Syndrome, Neurodegeneration, Tau, and Alternative Splicing. Additional areas listed in the board record include Phosphorylation, Kinase, Phosphatase, and TDP-43. Dr. Liu contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 65, indicating a sustained record of scholarly output and citation impact.
Department of Neurosurgery, University of Florida, Gainesville, United StatesNeurosurgery; Neuroscience; Subarachnoid hemorrhage; Traumatic brain injury
Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company SwiftScience, the pharmaceutical company ProPhos Neuroscience, and was a science advocate on Capitol Hill through the Washington Fellow’s program.
He has also served as president of the WVU chapters for the American Association of Pharmaceutical Scientists, Neurosurgery Interest group, and Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently Vice President of the UF House Staff Council, Chair of the Quality Improvement Committee, on the Board of Directors for the Alachua County Medical Society, and active member of Institutional Review Committee and Accreditation Requirements Review Committee. He is married to Noelle Lucke-Wold and has two children. As a family, they enjoy running with their dogs, rock climbing, and traveling. In his spare time, Brandon frequently runs half marathons and 10ks together with is wife. Brandon also enjoys reading, playing piano, discussing philosophy, and playing chess. He is currently a Pgy6 neurosurgery resident at University of Florida with pursuing endovascular enfolded training and was awarded the Dempsey Cerebrovascular Research Fellowship, SNS Fellowship, Van Wagenen Fellowship, R25 Grant, and SNIS Fellowship.
Department of Mathematics and Statistics, University of York, Toronto, CanadaBig data mining in biomedicine; Vaccination; Global health; Biostatistics; Data science
Nicola Luigi Bragazzi got his MD in general medicine and surgery from Genoa University (Genoa, Italy) in 2011, his PhD in biophysics from Marburg University (Marburg, Germany) in 2014 and his specialization in Public Health from Genoa University (Genoa, Italy) in 2017. He is a member of the Cochrane Association (Cochrane Reviewer) for the Cochrane Epilepsy Group. He has been awarded Young Knight of the Italian Republic by the President Carlo Azeglio Ciampi in 2005. Recently, in 2019, he has been nominated as one of the top five biomedical researchers worldwide aged less than 40 years in terms of number of publications, articles in Q1 biomedical journals, total impact factor and h-index. He is currently working on infectious disease and vaccination modelling and big data mining in biomedicine at York University.
Department of Pharmaceutical Sciences, College of Pharmacy, WSH, University of Nebraska Medical Center, Omaha, United StatesNanomedicine; Biophysics; DNA Replication and Recombination; Protein-DNA Interaction; Chromatin Structure and Dynamics; Alzheimer's Disease; Parkinson's Disease; Amyloid Protein Aggregation; Protein Misfolding; Alpha-Synuclein; Beta Amyloid; Protein–Protein Interaction; Computational Modeling; Nanoimaging; Single-Molecule Biophysics; Force Spectroscopy; Atomic Force Microscopy; AFM
Professor, UNMC Department of Pharmaceutical Sciences.
Dr. Lyubchenko received his doctoral training in Molecular Biophysics at the Moscow Institute of Physics and Technology, a top-ranked School in the former Soviet Union. He developed an active research program in the physical chemistry of nucleic acids at the Institute of Molecular Genetics in Moscow. He received the degree of Doctor of Science (the top scientific degree in the former USSR) for this research. He is currently a professor at Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE. Research in the Lyubchenko lab focuses on understanding fundamental mechanisms underlying health and disease, which are key to developing new and more effective diagnostics and medications. The research is categorized into four broad areas, with interplay and overlap among them (1) Structural genomics in relation to cancer and other diseases, (2) Molecular mechanisms Alzheimer’s, Parkinson’s and other protein aggregation diseases, (3) Protein-DNA interactions for novel approaches for HIV restriction.
1. Department of Environmental Health, Harvard T H Chan School of Public Health, Boston, MA, United States
2. Department of Pharmacology & Toxicology, University of Arizona, Tucson, AZ, United StatesBioinformatics; Machine learning; Deep learning; Genomics; Epigenetics
Research Scientist, Department of Pharmacology & Toxicology, University of Arizona, Tucson, AZ, United States.
Dr. Saurav Mallik is a computational biologist and bioinformatics researcher with expertise in machine learning, data mining, biostatistics, genomics, epigenomics, and biomedical data analysis. His research focuses on the development and application of computational and statistical approaches for analyzing high-dimensional biological and clinical datasets, with particular emphasis on disease classification, biomarker discovery, molecular pattern recognition, and precision medicine.
Dr. Mallik received his Ph.D. in Computer Science and Engineering from Jadavpur University, Kolkata, India, with doctoral research conducted at the Machine Intelligence Unit, Indian Statistical Institute, Kolkata. Before joining the University of Arizona, he held research and postdoctoral positions at Harvard T.H. Chan School of Public Health, the Center for Precision Health at the University of Texas Health Science Center at Houston, and the Division of Biostatistics at the University of Miami Miller School of Medicine.
His research contributions span cancer genomics, DNA methylation and gene expression analysis, graph- and rule-based learning algorithms, multi-omics integration, chronic disease prediction, and machine-learning-driven healthcare analytics. Through interdisciplinary work at the interface of pharmacology, toxicology, computational biology, and biomedical informatics, Dr. Mallik contributes to the advancement of data-driven approaches for understanding disease mechanisms, identifying diagnostic and prognostic markers, and supporting precision therapeutic strategies.
WiscNano, School of Pharmacy,University of Wisconsin-Madison, Madison, United StatesNanoBiomaterials; Advanced Drug/Gene Delivery Systems; Cancer Immunotherapy; Bone/tissue engineering
Dr. Mamidi holds the position of Scientist at WiscNano, School of Pharmacy, University of Wisconsin-Madison (UW-Madison), USA. His primary research focus lies in the innovative development of nano-formulations for co-drug-gene delivery and cancer immunotherapy. Prior to his affiliation with UW-Madison, Dr. Mamidi served as an Assistant Professor in the Department of Chemistry and Nanotechnology at Tecnologico de Monterrey (TEC). During his tenure at TEC, he spearheaded multidisciplinary research endeavors that integrated novel chemistries with nanoscale technologies to create advanced biomaterials for diverse biomedical applications. Dr. Mamidi’s team has achieved significant breakthroughs in the design of customizable biomaterials, tailored for applications such as drug delivery, orthopedic implants, tissue engineering, biomedical devices, and environmental remediation. His contributions to the field are well-documented, with over 45 research articles published in prestigious journals. Notably, his work has garnered more than 1000 citations, demonstrating his influential presence in the scientific community.
Acknowledging his outstanding achievements, Dr. Mamidi has received various accolades, including the prestigious 2015 Eli Lilly Award, the 2018 National Research System (SNI) award, and the 2021 SNI award from the National Council for Science and Technology. In recognition of his exemplary contributions, Dr. Mamidi was honored as an outstanding research professor at the School of Engineering and Science, TEC in 2020. Furthermore, Dr. Mamidi actively contributes to the dissemination of knowledge within his domain as an editorial member for several reputable nanomedicine and nanotechnology journals. His dedication to interdisciplinary research and commitment to advancing biomaterials for biomedical applications further underscore his standing as a key researcher in the field.
Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyAmyloidosis; Renal Biopsy; Autoinflammatory Diseases; Pathology, Serum; Multiple Myeloma; Rheumatoid Arthritis; Chemotherapy; Oncology; Hematology
Department of Internal Medicine, University of Genova, Genova, ItalyPharmacogenomics; Immunology; Vaccines; Biologics; HIV; Allergies; Atherosclerosis; Autoimmunity; Immune-mediated diseases; Immunodeficiency; Neuroendocrine-immunology
Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).
His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.
Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".
Leading scientist of the molecular nanomedicine lab, Department of translational medicine, Sirius University of Science and Technology, Krasnodar,RussiaNanomedicine; Immune Metabolism; Cancer; Sepsis; Pulmonary Biology
Doctor of Philosophy, Leading Scientist at Sirius University of Science and Technology.
Dr. Parodi is a biological/medical researcher with significant experience in drug formulation, PK, nanomedicine, drug delivery, and immune metabolism. His research activity is devoted to designing, performing, analyzing, and interpreting data derived from extensive biological testing, material characterization, toxicology, and drug pharmacokinetics.
Leading scientist of the molecular nanomedicine lab, Department of translational medicine, Sirius University of Science and Technology, Krasnodar,RussiaNanomedicine; Immune Metabolism; Cancer; Sepsis; Pulmonary Biology
Doctor of Philosophy, Leading Scientist at Sirius University of Science and Technology.
Dr. Parodi is a biological/medical researcher with significant experience in drug formulation, PK, nanomedicine, drug delivery, and immune metabolism. His research activity is devoted to designing, performing, analyzing, and interpreting data derived from extensive biological testing, material characterization, toxicology, and drug pharmacokinetics.
Key Laboratory of Protein and Peptide Pharmaceuticals, CAS-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, ChinaProteins 100; Cancer Associated Fibroblast; Fibroblast Activation Protein Alpha; Tumor Microenvironment
Professor at Zhengzhou University, Researcher at the Institute of Biophysics, Chinese Academy of Sciences, National Science Fund for Distinguished Young Scholars awardee, Chief Scientist of the National "973" Program, and Executive Committee Member of the Tumor Immunology and Biotherapy Branch of the Chinese Society for Immunology. Currently serves as the Director of the Immunology Center at the Medical Sciences Academy of Zhengzhou University and concurrently as the Director of the Medical Research Center at the First Affiliated Hospital of Zhengzhou University.
Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, ItalyAnatomy; Histology; Morphological and Functional Aspects of Stromal Cells and Endothelial Cells; Angiogenesis; Tissue Fibrosis; Systemic Sclerosis; Scleroderma
Researcher at Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, Italy.
Department of Medical Sciences, University of Ferrara, Ferrara, ItalyCancer; MCC; MCPyV; Large T Antigen; Antibody; Antigen; ELISA; Infertility; SARS-CoV-2; Prevalence
PhD, Researcher, Principal investigator at Azienda Ospedaliera Universitaria San Martino di Genova.
Dr. Rotondo's main research interests are cell and tumor biology, epigenetics, virology, viral oncology.
Institute of Neurophysiopathology (INP), Aix-Marseille University, Marseille, FranceAntimicrobial Peptides; Antibacterial; Antibiotics; Structure-Activity Relationships; Bacteriocins; Drug Design; Peptide Engineering; Antivirals; Infectious Disorders
PhD & HDR, French National Centre for Scientific Research.
Dr. Sabatier is a Director of Research at CNRS affiliated to the Institute of NeuroPhysiopathology, UMR 7051, Marseille (France). He is acting as: Editor-in-Chief of "Journal of Current Toxicology and Venomics"; Editor-in-Chief of "Coronaviruses"; Topic Editor-in-Chief of "Antibiotics" (IF: 4.3); Associate Editor of "Frontiers in Pharmacology" (IF:4.4); Associate Editor of "Journal of Advanced Research" (IF: 11.4); Editorial Board Member of 75 journals. Reviewer for journals with IF up to 35.
Dept. of Applied Sciences, Indian Institute of Information Technology, Allahabad, IndiaBiochemistry; Nanobiotechnology; Bioinformatics
Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania Luigi Vanvitelli, Naples, ItalyHeart Failure; Atrial Fibrillation; Echocardiography; Electrocardiography; Clinical Cardiology; Chronic Heart Failure; Cardiac Function; Myocardial Infarction; Hypertension; Cardiovascular Medicine
Dr. Sardu is an Associate Professor at the Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy. He authored/co-authored 155 publications and 4739 citations with an h-index of 41 (Scopus, December 2023). His research interests focus on heart failure, atrial fibrillation, echocardiography, electrocardiography, clinical cardiology, chronic heart failure, cardiac function, myocardial infarction, hypertension, and cardiovascular medicine.
Department of Pharmacology, Yong Loo Lin School of Medicine, Queenstown, SingaporeCancer; Inflammation; Transcription factors; Vitamin; Apoptosis
Associate Professor at the Yong Loo Lin School of Medicine, Queenstown, Singapore.
Dr. Sethi is the editorial board member of 11 different international journals.
AVAILABILITY
-
Collaborative projects
-
Industry Projects
-
Masters Research or PhD student supervision
-
Join a web conference as a panellist or speaker
-
Mentoring (long-term)
-
Media enquiries
-
Mentoring (short-term)
Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, Boston, MA, United StatesMultiple Myeloma; Esophageal Cancer; Genomic Instability; DNA Damage Respons
Lead Scientist, Department of Medical Oncology, Harvard (Dana-Farber) Cancer Institute, Boston, MA, United States.
Dr. Masood A. Shammas is a cancer researcher with expertise in genomic instability, clonal evolution, DNA repair, telomere biology, and oncogenesis. He received his doctorate in Biochemistry and Molecular Biology from the University of Arkansas for Medical Sciences and completed postdoctoral training at the Arkansas Cancer Research Center and the University of Arkansas for Medical Sciences. He subsequently served as an Instructor at Harvard Medical School and Harvard (Dana-Farber) Cancer Institute.
Dr. Shammas’s research focuses on understanding the molecular mechanisms underlying genomic instability and cancer progression, using multiple myeloma and Barrett’s esophageal adenocarcinoma as major model systems. His work has demonstrated the role of dysregulated homologous recombination in genomic instability, disease progression, and drug resistance, and has contributed to the identification of potential therapeutic strategies to inhibit or delay genomic evolution in cancer.
He has authored and co-authored numerous peer-reviewed publications and has served as an editor, guest editor, and reviewer for scientific journals. His research integrates molecular oncology, DNA repair biology, telomere maintenance, and translational therapeutic development, with the goal of identifying novel targets and strategies for cancer prevention, progression control, and treatment.
1. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, India
2. Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab EmiratesCancer Therapeutic; Kinase Inhibitors; Natural Compounds; Protein Biochemistry; Drug Design and Discovery
Dr. Mohammad Anas Shamsi is a Research Assistant Professor at the Center for Medical and Bio-Allied Health Sciences Research. His research area is Structure-based Drug Design and Discovery. He is working in the most exciting areas of medicinal chemistry with a special focus on structure-based drug design and discovery, targeting the discovery of new drugs for the treatment of Cancer and Alzheimer's and related neurodegenerative diseases.
Chinese Center for Disease Control and Prevention, Beijing, ChinaMicrobial Genetics and Pathogenesis; Microbiological Diagnosis and Biosecurity
Professor Hongbin Song is affiliated with Chinese Center for Disease Control and Preventiondisabled, Beijing, China.
Dr. Song's research interests include Microbial Genetics and Pathogenesis and Microbiological Diagnosis and Biosecurity. Dr. Song contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 40, indicating a sustained record of scholarly output and citation impact.
Department of Pharmacy (DIFARMA), University of Salerno, Fisciano, ItalyCancer; Carcinogenesis; Lung Cancer; Drug Resistance; Immunotherapy; Inflammation
Associate Professor in Pharmacology and Pharmacotherapy, University of Salerno, Italy.
2024 to present: Member of the IUPHAR Cancer Pharmacology Committee
2010 to present: Member of the Italian Society of Pharmacology (SIF)
Member of the SIF Oncology Pharmacology Group, directed by Prof. Mini
Co-coordinator with Prof. Giorgio Minotti of the Clinical Oncology Pharmacology subgroup
Co-coordinator with Prof. Giuseppe Nocentini of the Oncology Immunopharmacology subgroup
Member of the SIF Environmental Toxicology subgroup: coordinated by Prof. Raffaella Sorrentino
2022 to present. Member and Ambassador of the European Association of Cancer (EACR) (EACR33315 member)
2015 to present: Member of the Universal Scientific Education and Research Network, USERN, "Cancer Immunology project" section: https://usern.tums.ac.ir/Group/Info/CIP
2013 to present: Member of the European Respiratory Society (ERS)
2011 to present: Member of the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA)
Department of Experimental Medicine, Sapienza University, Rome, ItalyCell Culture; Cell Signaling; Cancer Biology; PCR; Molecular Biology; Gene Regulation; Epigenetics; Apoptosis; Western Blot Analysis
Doctorate, Associate Professor, Sapienza University of Rome, Rome, Italy.
EDUCATION AND CAREER
2015-present Associate Professor, General Pathology, MED/04
2010-2015 Assistant professor, General Pathology, MED/04
2007-2010 Assistant professor, Department of Cellular and Molecular Pathology, IRCCS San Raffaele Pisana, Rome.
2004-2007 Post-Doctoral Fellow, Department of Experimental Medicine, Sapienza University.
2000-2004 Assistant professor, Thomas Jefferson, Philadelphia, PA, USA
1997-2000 Research Technician, Thomas Jefferson, Philadelphia, PA, USA
1999-2003 PhD in Human Pathology, Department of Experimental Medicine, Sapienza University.
1994 Degree in Biology, Tor Vergata University, Rome.
MOST RELEVANT RESEARCH LINES
1) Hypoxia and inflammation in tumor progression
2) Sirtuins in cellular physiology and pathology
3) Mechanoreceptors and sirtuins in space biomedicine
COLLABORATIONS
Prof. Pankaj K Singh, University of Nebraska, Omaha, NB, USA
Prof. Gregg L Semenza, Johns Hopkins University, Baltimora, MD, USA
Prof. Matteo A Russo, MEBIC, San Raffaele Pisana, Roma
Dr Federica Limana, Università San Raffeale, Roma.
Prof. Antonello Mai, Università Sapienza
Prof. Mariano Bizzarri, Università Sapienza
Prof. Marco Cordani, Complutense University, 28040 Madrid, Spain.
Department of Applied Biology and Chemical Technology and PolyU Laboratory for Probiotics and Prebiotics in Human Health, The Hong Kong Polytechnic University, Hong Kong SAR, ChinaCancer Therapy; Probiotics; Microbiota; Renal Diseases; Cellular Immunotherapy; Drug Development; Inflammatory Bowel Disease
Assoicate Editor (Frontiers in Pharmacology).
of cancer and inflammatory diseases; and (3) BK polyomavirus in renal transplantation and outcomes.
School of Pharmacy, University of Camerino, Camerino, ItalyNeuroscience; Cell Culture; Synthesis; Neurobiology; Neuropharmacology; Neurobiology and Brain Physiology; Neurophysiology; Neurodegeneration; Electrophysiology; Neurodegenerative Diseases
PharmD, PhD, ClinPharmD
Professor (Associate) at Università di Camerino
School of Medicine, The City University of New York, New York, United StatesChagas Disease; Host–pathogen Interactions; Immunity; Drug and Vaccine Discovery
School of Mathematics and Statistics, Henan University, Kaifeng, ChinaSystems Biology; Biostatistics; Omics Data Analysis
Henan Provincial Distinguished Professor, Professor and Doctoral Supervisor at Henan University. Recipient of the Henan Provincial Outstanding Youth Fund, Henan Provincial Excellent Young Scientists Fund, Henan Provincial University Innovation and Technology Talent Program, and Henan Provincial Key Young Faculty Program; Leader of the Kaifeng Municipal Innovative Science and Technology Team.
International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, ChinaRecombinant Therapeutic Protein; Efficient Mammalian Cell Expression System; Gene Expression Regulation
Dr. Tianyun Wang is affiliated with International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, China.
Dr. Wang's research interests include Recombinant Therapeutic Protein, Efficient Mammalian Cell Expression System, and Gene Expression Regulation. Dr. Wang contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 28, indicating a sustained record of scholarly output and citation impact.
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou, ChinaImmunology; Molecular and Cellular Biology; Ophthalmology; Cancer Biology
Associate Professor, Senior Investigator, Taishan Scholarship Professor.
Dr. Wang received a Bachelor degree in Basic Medicine from Beijing Medical University (now Health Science Center of Peking University) and a PhD degree in pathophysiology from the Academy of Military Medical Sciences. After postdoc training in the Second Military Medical University and the University of Iowa (1996-2003), he started his career track in the University of Iowa, Shandong Academy of Medical Sciences, Soochow University, Xiamen University and Xi’an Jiaotong-Liverpool University sequentially. His research is to understand the mechanisms underlying the pathogenesis or treatment of diseases from the viewpoints of basic medical scientists. He published over 50 SCI-indexed papers in international journals plus over 50 papers in non-SCI-indexed journals covering immunology, microbiology, molecular biology, cellular biology, pharmacology (disciplines in sense of basic medicine), or hematology, oncology, ophthalmology, dermatology, autoimmune diseases (disciplines in clinical medicine). He also published two books as editors and issued nine inventory patents. He is member of several academic societies and on journal editorial boards. He pursues after novelty in science and enjoys research, especially on innovative theories. In the last ten years, one of his teams interests has been the functions of the gene MXRA7 and disclosed the clues to the significance of this gene in biomedical processes. His team has won several awards from Chinese agents or international academic societies.
KinderGenome Genetics Private Practice, Dallas, United StatesClinical Genetics; Relation of DNA Change to Genetic Diseases and Syndromes; Ehlers-Danlos syndrome and Connective Tissue Dysplasias
Dr. Golder Wilson, MD is a pediatrician in Lubbock, TX and has over 50 years of experience in the medical field.
Dr. Golder Wilson is a board-certified medical geneticist who became interested in EDS after 40 years of experience with syndromes involving intellectual disability, birth defects, and autism. After scholarship yielding 100 articles and 4 books on ~25,000 patients with the latter disorders, he has described the clinical and DNA findings of 2000-plus EDS patients in another 20 articles and a recent book available at The DNA of Ehlers-Danlos and Long COVID19 Syndromes: Healing Their Flexibility, Fatigue, and Fear: 9798313797625: Medicine & Health Science Books at Amazon.com.
1. Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, Henan, China;
2. School of Stomatology, Henan University, Kaifeng, Henan, ChinaHydrogen Sulfide; Nucleoprotein; Metabolic Diseases
Full Professor of Physiology and Vice President of School of Stomatology at Henan University.
Dr. Dongdong Wu obtained his PhD from Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China. Currently he serves as Full Professor of Physiology and Vice President of School of Stomatology at Henan University and Executive Director of Henan International Joint Laboratory for Nuclear Protein Regulation (at Henan University). He has been elected to membership within a number of scientific committees across China, including Chinese Society of Immunology, Chinese Anti-Cancer Association, and Chinese Society for Microbiology. Dr. Dongdong Wu has authored more than 90 original research papers and review articles, upon research interests including hydrogen sulfide, nucleoprotein, and metabolic diseases.
State Key Laboratory of Tea Biology and Utilization, Anhui Agricultural University, Hefei, ChinaVascular Biology
Professor Zhongwen Xie is a Wangjiang Scholar and a Doctoral Supervisor in the School of Tea and Food Science and Technology at Anhui Agricultural University. He received a bachelor's degree from East China Normal University in 1986 and a PhD from the Chinese Academy of Sciences in 1999. Previously, he was a Post-Doctoral Fellow and Senior Scientist at the University of Kentucky in the United States. Currently, he serves as an executive member of the National Council of Food Nutrition and Health.
epartment of Biochemistry and Molecular Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, ChinaIdentify Novel Onco-kinase; Mechanism of Resistance of TKI in NSCLC; Mechanism of Skin Inflammation Diseases
Professor Feng Zhu is affiliated with department of Biochemistry and Molecular Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, China.
Dr. Zhu's research interests include Identify Novel Onco-kinase, Mechanism of Resistance of TKI in NSCLC, and Mechanism of Skin Inflammation Diseases. Dr. Zhu contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 37, indicating a sustained record of scholarly output and citation impact.
1. Department of Biomedical and Clinical Science, University of Milan, Milan, Italy
2. Department of Pediatrics, Buzzi Children’s Hospital, Milano, ItalyPediatrics; Nutrition; Infectious Diseases; Health Care; Telemedicine; Translational Research; Rare Diseases; Non-Communicable Disaeses
Full Professor of Pediatrics at the School of Medicine, University of Milan, Italy
Head of the Department of Pediatrics, University of Milan, at the Children Hospital, Milan, Italy
Director of Pediatric Clinical Research Center
Vice Director of Biomedical and Clinical Science Department Università degli Studi di Milano
Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaCancer Metabolism; Tumor Microenvironment; Proteomics; Cancer Immunology
Dr. Li Cui serves as an Associate Professor at Southern Medical University. He earned his Doctor of Dental Surgery (DDS) degree from Sun Yat-Sen University and later completed his Ph.D. at the University of California, Los Angeles. Specializing in the study of the tumor microenvironment, Dr. Cui aims to bridge molecular and cellular mechanisms with clinical applications. He has an impressive publication record, having authored over 40 articles in prestigious, SCI-indexed journals such as ACS Nano, Analytical Chemistry, and Cancer Communications.
Keck School of Medicine of USC, Los Angeles, United StatesCancer Metastasis to the Brain; Blood-Brain Barriers; GABA Metabolism by Tumor Cells; Snake Venom Proteins, Toxins; Venom Proteins
Diganta is a Postdoctoral Researcher working on brain metastasis through neurobiology perspectives (microenvironment and brain barriers). Diganta received his PhD in snake venom protein chemistry from Tezpur University, Assam, India and has a sound experience in proteomics. He earned the technique of handling snakes and venom milking. Diganta enjoys a good guitar and photography binge but can also be found in the midst of wilderness.
Srividya Swaminathan Lab, Department of Systems Biology, City of Hope - Biomedical Research Institute, California, United StatesNK Cells-based Immunotherapy; Acute Lymphoblastic Leukemia; Allergy and Osteoimmunology
B.S., M.S., Ph.D.
Member, American Society of Hematology (ASH) | 2025
DBT International Travel Grant | Govt. of India | 2016
Senior Research Fellowship (CSIR) | Govt. of India | 2014-2019
Junior Research Fellowship (CSIR) | Govt. of India | 2012-2014
Qualified CSIR-JRF Exam (Rank 29) | 2011
Graduate Aptitude Test in Engineering (GATE-2011) | Qualified
National Eligibility Test Lectureship (NET) | Qualified, 2010
Cullen College of Engineering, Houston, United StatesPsychiatric disorders; Monoaminergic systems; GABAergic systems; Anxiety; Stress; Depression; Substance abuse; Genetic basis of emotionality; Developmental basis of Emotionality; Cellular and molecular neuroanatomy of rodent and pstmortem human brain; Light sheet microscopy; Large image-data analysis; Multiplexed fluorescence in situ hybridization; Brain transparency techniques; iDISCO
Cullen College of Engineering, Houston, United StatesPsychiatric disorders; Monoaminergic systems; GABAergic systems; Anxiety; Stress; Depression; Substance abuse; Genetic basis of emotionality; Developmental basis of Emotionality; Cellular and molecular neuroanatomy of rodent and pstmortem human brain; Light sheet microscopy; Large image-data analysis; Multiplexed fluorescence in situ hybridization; Brain transparency techniques; iDISCO
Huashan Hospital, Fudan University, Shanghai, ChinaMitochondrial Dynamics; Stem Cells; Macrophage Polarization; Extracellular Vesicles
Professor, Research Director at Fudan University.
Dr. Zhiwen Luo, Executive Director of Fudan University-Dr.Kong Joint Laboratory of Sports Medicine. Director Assistant, Institute of Sports Medicine, Huashan Hospital. Holds editorial roles as EIC/Associate Editor/Editorial Board/Youth Editorial Board for 40 academic journals, reviewer for over 80 SCI journals, and guest editor for over 10 SCI journals, such as Materials Today.
Friedrich-Loeffler-Institute, Greifswald, GermanyAntimicrobial Resistance; WGS; Epidemiology; Genetics; Antimicrobial Susceptibility Testing; Molecular Biology; Animal Production; Mass Spectrometry; Zoonotic Diseases; Foodborne Pathogens; Food Hygiene and Control
Dr. Amira Moawad is currently working as a Professor at Animal Health Research Institute. She became from 2016 until now a scientific researcher at Friedrich-Loeffler-Institute. Her PhD was on different mechanisms of antimicrobial resistance in pathogens of human and animal origin in FU Berlin. She practices research in Microbiology and Molecular Biology. Since 2017, she has cooperated in international Projects funded by German federal foreign Office. She is concerned with One Health and WGS
University of California, Irvine, California, USABioinformatics; Genomics; Proteomics; Single-Cell Multi-omics; and Translational Neuroscience
Dr. Madhu Sudhana Saddala, Ph.D, working as a Bioinformatics Scientist in the University of California, Irvine, CA. USA
National Cancer Institute, NIH, United StatesTumor Biology; Pancreatic Cancer; MiRNAs; Molecular Mechanism of Cancer; Translational Medicine; Biomarkers
Staff Scientist, Laboratory of Human Carcinogenesis, NCI, NIH, Bethesda, MD
Fellows Award for Research Excellence (FARE), NIH, 2018
Outstanding research in the field of pancreatic cancer and treatment, current advances in
pancreatic cancer research and treatment poster presentation award, NIH, 2014
Excellent Doctoral Dissertation, Peking Union Medical College, Tsinghua University, 2013
Second-class scholarships of Peking Union Medical College, Tsinghua University, 2009, 2011
Excellent graduate student of Jiangsu Normal University, 2008
Excellence Award of National English Contest for College Students, 2004
First-class scholarships of Jiangsu Normal University, 2001, 2002, 2004
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH), Guangdong, ChinaiPSC; Pluripotent Stem Cells; Reprogramming; Nuclear Reprogramming; Cytoplasm; Mitochondria; Somatic Cell Reprogramming; Mitochondrial DNA; Reactive Oxygen Species; Mitochondrial Dynamics
Associate researcher at Chinese Academy of Sciences
Shenzhen University, Shenzhen, ChinaPCR; Gel Electrophoresis; DNA Extraction; Electrophoresis; RNA Isolation; DNA Gel Electrophoresis; DNA Amplification; Agarose Gel Electrophoresis; RNA; DNA Sequencing
Research Associate, University of Chinese Academy of Sciences (UCAS), China.
Department of Dental Implantology, College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, Anhui, ChinaCellular Biology & Molecular Biology of Bone Aging; Stem Cell Lineage Fates related Epigenetic Regulation; 3D Genomics; Stem Cell-based Therapy for Bone Regeneration; Screening of Jaw Bone Loss related Risk Factors
Doctor of Medicine, Associate professor at Anhui Medical University.
Since 2021, Dr. Zhang has held positions at Anhui Medical University, advancing from a lecturer to an associate professor. Recognized as a Category D high-level talent in Hefei City (a municipal leading talent), he is a Doctor of Dental Medicine, an attending doctor, and a mentor for master's students.
Zhejiang Agriculture and Forestry University, Hangzhou, ChinaCardiology; Oncology; Neurology; Vascular Biology; Mitochondria; ROS; Endothelial Function
Professor, College of Forestry and Biotechnology, Zhejiang Agriculture and Forestry University, Hangzhou, China.
Prof. Jin Zhang is a plant molecular biology and forest biotechnology researcher with expertise in wood formation, plant cell wall development, and the molecular regulation of growth and stress responses in woody plants. His research focuses on the genetic and molecular mechanisms underlying xylem differentiation, cambium activity, secondary cell wall biosynthesis, and biomass-related traits, with poplar serving as an important model system.
Prof. Zhang’s work has contributed to the understanding of transcriptional regulation, hormone signaling, calcium signaling, reactive oxygen species homeostasis, and gene regulatory networks involved in wood development and environmental adaptation. His research also addresses drought response, plant productivity, lignin composition, vascular development, and the functional characterization of genes related to woody plant growth.
Through interdisciplinary studies integrating molecular genetics, functional genomics, plant physiology, and forest biotechnology, Prof. Zhang contributes to advancing knowledge of gene- and protein-mediated regulatory mechanisms in plant development and stress adaptation, as well as to the improvement and sustainable utilization of woody biomass resources.
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, ChinaSingle-cell multi-omics; spatial transcriptomics; tumor immune microenvironment; cancer molecular mechanisms; biomaterials and regenerative medicine; novel drug materials; skin and craniomaxillofacial tumors; disease epidemiology
1. Centre for Precision Health, Edith Cowan University, 270 Joondalup Drive, Perth, WA 6027, Australia; 2. School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Perth, WA 6027, AustraliaGenomics; Glycomics
Department of Medical Biotechnology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, IranBioinformatics; Gene Expression; Epstein Barr Virus; Cancer Research; microRNA
Center of Excellence in Environmental Studies, King Abdul Aziz University, Jeddah P.O Box: 80216, Jeddah 21589, KSA.Antimicrobial Agents; Nanoformulation; Silver Nanoparticles; Phosphate Solubilization; Biofilm
Medical Science and Technology Innovation Center, Shandong First Medical University, 271000, Jinan, ChinaCancer Proteomics and Proteoformics; Cancer Multiomics and Biomarkers; Molecular Targets for 3P Medicine and Precision Medicine in Cancer
Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USAGene and Immunotherapy for Vascular Diseases; Ageing; Neurobiology; CVD
Leading scientist of the molecular nanomedicine lab, Department of translational medicine, Sirius University of Science and Technology, Krasnodar,RussiaNanomedicine; Immune Metabolism; Cancer; Sepsis; Pulmonary Biology
Rogel Cancer Center, University of Michigan, Ann Arbor, MI48109, USACancer Biology; Tumor Microenvironment; Lymphoma